ROCKVILLE, Md.--(BUSINESS WIRE)-- Emergent BioSolutions Inc. (EBS) announced today that it will hold its Annual Meeting of Stockholders on Thursday, May 17, 2012 beginning at 9:00 AM Eastern at the InterContinental Harbor Court, 550 Light Street, Baltimore, Maryland 21202.

Following the formal portion of the meeting, a member of the companys senior management will provide a brief corporate update, including a discussion of the companys business activities, financial outlook and current news.

Interested parties may listen to the Annual Meeting via webcast by visiting the Emergent BioSolutions website at www.emergentbiosolutions.com. The webcast will be archived on the companys website under Investors.

About Emergent BioSolutions Inc.

Emergent BioSolutions protects and enhances life by developing and manufacturing vaccines and therapeutics that are supplied to healthcare providers and purchasers for use in preventing and treating disease. Emergent's marketed and investigational products target infectious diseases, oncology and autoimmune disorders. Additional information about the company may be found at www.emergentbiosolutions.com.

Emergent BioSolutions Inc.
Investor Contact:
Robert G. Burrows
Vice President, Investor Relations
301-795-1877
BurrowsR@ebsi.com
or
Media Contact:
Tracey Schmitt
Vice President, Corporate Communications
301-795-1800
SchmittT@ebsi.com

Source: Emergent BioSolutions Inc.